Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study

被引:64
作者
Schockaert, Silke [1 ]
Poppe, Willy [1 ]
Arbyn, Marc [2 ,3 ]
Verguts, Tom
Verguts, Jasper [1 ,4 ]
机构
[1] Catholic Univ Louvain, Univ Hosp Gasthuisberg, Dept Obstet & Gynecol, B-3000 Louvain, Belgium
[2] Sci Inst Publ Hlth, Brussels, Belgium
[3] European Canc Network, Lyon, France
[4] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium
关键词
cervical intraepithelial neoplasia; hysterectomy; Papanicolaou smears; vaginal intraepithelial neoplasia;
D O I
10.1016/j.ajog.2008.02.026
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Hysterectomy with concomitant cervical intraepithelial neoplasia (CIN), is often considered a definitive treatment for CIN, but development of subsequent vaginal intraepithelial neoplasia (VAIN) is known to range from 0.9% to 6.8%. STUDY DESIGN: In a retrospective analysis of 3030 women with CIN2+ without history of VAIN in the University Hospital Gasthuisberg, Leuven, Belgium, from January 1989 until December 2003, we identified 125 women who underwent a hysterectomy within 6 months after diagnosis of CIN2+ and reviewed their postoperative Papanicolaou smears. RESULTS: Thirty-one patients (24.8%) were lost to follow-up. Seven of the 94 women in the follow-up group (7.4%) developed VAIN2+, of which 2 were invasive vaginal cancers. Median interval between hysterectomy and diagnosis of VAIN2+ was 35 months (5-103 months). Women with recurrence were significantly older (P = .003). CONCLUSION: Hysterectomy may not be considered as a definitive therapy for CIN2+ because the incidence rate of subsequent VAIN2+ is as high as 7.4%.
引用
收藏
页码:113.e1 / 113.e5
页数:5
相关论文
共 25 条
[1]   Burden of cervical cancer in Europe: estimates for 2004 [J].
Arbyn, M. ;
Raifu, A. O. ;
Autier, P. ;
Ferlay, J. .
ANNALS OF ONCOLOGY, 2007, 18 (10) :1708-1715
[2]   Clinical utility of HPV-DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence [J].
Arbyn, M ;
Paraskevaidis, E ;
Martin-Hirsch, P ;
Prendiville, W ;
Dillner, J .
GYNECOLOGIC ONCOLOGY, 2005, 99 (03) :S7-S11
[3]   Clinical applications of HPV testing: A summary of meta-analyses [J].
Arbyn, Marc ;
Sasieni, Peter ;
Meijer, Chris J. L. M. ;
Clavel, Christine ;
Koliopoulos, George ;
Dillner, Joakim .
VACCINE, 2006, 24 :78-89
[4]  
Babarinsa I, 2006, J Obstet Gynaecol, V26, P157
[5]   Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening [J].
Bray, F ;
Loos, AH ;
McCarron, P ;
Weiderpass, E ;
Arbyn, M ;
Moller, H ;
Hakama, M ;
Parkin, DM .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) :677-686
[6]  
Gadducci A, 2003, EUR J GYNAECOL ONCOL, V24, P513
[7]  
GALLUP DG, 1975, OBSTET GYNECOL, V46, P334
[8]   HOW FREQUENTLY NEED VAGINAL SMEARS BE TAKEN AFTER HYSTERECTOMY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA [J].
GEMMELL, J ;
HOLMES, DM ;
DUNCAN, ID .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (01) :58-61
[9]   THE MANAGEMENT OF THE PATIENT WITH ABNORMAL VAGINAL CYTOLOGY FOLLOWING HYSTERECTOMY [J].
IRELAND, D ;
MONAGHAN, JM .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1988, 95 (10) :973-975
[10]   Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins [J].
Itsukaichi, M ;
Kurata, H ;
Matsushita, M ;
Watanabe, M ;
Sekine, M ;
Aoki, Y ;
Tanaka, K .
GYNECOLOGIC ONCOLOGY, 2003, 90 (02) :387-389